Rosa Sorrentino

Prof. Rosa Sorrentino

Sapienza Univeristy of Rome
orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DEDavid M. Evans
David M. Evans
CSChris C A Spencer
Chris C A Spencer
JPJennifer J Pointon
Jennifer J Pointon
ZSZhan Su
Zhan Su
DHDavid Harvey
David Harvey
PDPeter Donnelly
Peter Donnelly

1 June 1985 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
AKA. J. Korman
A. J. Korman
JBJ. M. Boss
J. M. Boss
TST. Spies
T. Spies
RSRosa Sorrentino
Rosa Sorrentino
KOK. Okada
K. Okada
JSJ. L. Strominger
J. L. Strominger

1 July 1981 in Nature
Verified
Journal Article
Closed access
PDF file
GCGiorgio Corte
Giorgio Corte
FCFranco Calabi
Franco Calabi
GDGuido Damiani
Guido Damiani
ABAntonio Bargellesi
Antonio Bargellesi
RTRoberto Tosi
Roberto Tosi
RSRosa Sorrentino
Rosa Sorrentino

1 April 1997 in Hepatology
Verified
Journal Article
Open access
PDF file
APA Penna
A Penna
GPG Del Prete
G Del Prete
ACA Cavalli
A Cavalli
ABAntonio Bertoletti
Antonio Bertoletti
MDMario Milco D'Elios
Mario Milco D'Elios
CFC Ferrari
C Ferrari
The cytokine pattern secreted by T cells on viral antigen recognition is believed to exert a profound influence on both the type of disease caused by the infecting agent and the final outcome of the viral infection. To characterize the cytokine pattern associated with spontaneous resolution of acute hepatitis B, we analyzed interferon gamma (IFN-γ), interleukin (IL)-4, and IL-5 production by a wide series of hepatitis B virus (HBV) nucleocapsid-specific T-cell lines (34 lines) and T-cell clones (71 clones) derived from the peripheral blood of 13 patients during the acute or recovery phase of hepatitis B (2 and 7 of them were studied only in the recovery or the acute phase, respectively, and 4 during both). Most T-cell lines (67%) and clones (77%) isolated during the acute phase of infection expressed a T-helper (Th) 1 cytokine profile dominated by the production of IFN-γ. A larger proportion (74%) of T-cell lines produced several years after resolution of hepatitis was able to secrete not only IFN-γ, but also IL-4 and IL-5 (Th0-like cells). Results indicate that the antigen-specific fraction of peripheral blood T cells in acute self-limited hepatitis B selectively secrete Th1-type eytokines, suggesting that Th1-mediated effects may contribute not only to liver cell injury, but probably also to recovery from disease and successful control of infection.

1 November 1995 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MDMauro D'Amato
Mauro D'Amato
MFMaria Teresa Fiorillo
Maria Teresa Fiorillo
CCCarlo Carcassi
Carlo Carcassi
AMAlessandro Mathieu
Alessandro Mathieu
AZAngelo Zuccarelli
Angelo Zuccarelli
RSRosa Sorrentino
Rosa Sorrentino

1 July 2000 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MFMaria T. Fiorillo
Maria T. Fiorillo
MMMonica Maragno
Monica Maragno
RBRichard Butler
Richard Butler
MDMaria L. Dupuis
Maria L. Dupuis
RSRosa Sorrentino
Rosa Sorrentino
HLA-B27 is highly associated with ankylosing spondylitis (AS), but the mechanism is unknown. Among the HLA-B27 alleles, B*2709, which differs by one amino acid from the susceptible B*2705, is not associated with the disease. Here, we analyze the reactivity, in patients with AS and in healthy controls carrying the B*2709 or B*2705 alleles, to an EBV epitope derived from LMP2 (236-244) and to a sequence-related self-peptide from vasoactive intestinal peptide receptor 1 (VIP1R 400-408). We found that both B*2705+ and B*2709+ subjects possess LMP2 236-244–specific, HLA-B27–restricted T cells, whereas only the B*2705+ individuals respond significantly to VIP1R 400-408. These results prompted us to compare, by IFN-γ ELISPOT analysis, the T-cell response to VIP1R 400-408 in patients with AS versus B*2705 healthy controls. The data show that VIP1R 400-408–specific reactivity is a major feature of the patients with AS. These findings show, for the first time to our knowledge, a widespread reactivity in patients with AS against a self-epitope that exhibits some features of a putative “arthritogenic” peptide.